Dr. Agarwal’s Health Care nears 568 after Q2 profit jump

Dr. Agarwal’s Health Care closed at ₹537.30 on 9 Nov 2026, below the 568 hurdle, after Q2 FY27 profit rose 55.8% to ₹57 crore. Dr. Agarwal’s Health Care Limited [ AGARWALEYE ] gained the most among healthcare stocks on Monday, 9 November 2026. The daily candle closed at ₹537.30, up 4.41%. The move follows Q2 FY27 results. Revenue from operations grew 31.4% year on year to ₹655 crore. Profit after tax rose 55.8% to ₹57 crore. In H1, surgeries rose 18.8% to 186,923 and the network reached 324 facilities by 30 September 2026. This matters because profit is growing faster than revenue. H1 profit after tax margin improved to 8.7% from 7.4%. The chart trend is bullish. Price has climbed from a swing low near 453, and RSI(14) reads 70.68 against a signal line at 57.46, so momentum is strong but near overbought. The stock was rejected twice near 568, in late 2025 and August 2026, which makes 568 the major hurdle. Support sits at 490. A close above 568 on rising volume would open price discovery. A close below 490 would weaken the structure. Until then, watch the 539.80 day high and volume on the approach to 568. Stance: bullish above 490, with 568 as the test. Disclosure: I do not hold any position in this stock. This is not a recommendation to buy or sell. Investments in securities markets are subject to market risks. Read all related documents carefully before investing.